Non-conventional fotemustine schedule as second-line treatment in recurrent malignant gliomas: Survival across disease and treatment subgroup analysis and review of the literature

Fotemustine (FTM) is a treatment option in recurrent malignant gliomas (MGs) after first-line Stupp treatment. The efficacy and the safety of fractionated FTM schedule proposed by Addeo et al was analysed in the present study in recurrent MGs patients. A retrospective analysis on 40 recurrent MGs pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Prelaj, Arsela, Rebuzzi, Sara Elena, Grassi, Massimiliano, Salvati, Maurizio, D'Elia, Alessandro, Buttarelli, Francesca, Ferrara, Carla, Tomao, Silverio, Bianco, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313958/
https://www.ncbi.nlm.nih.gov/pubmed/30655978
http://dx.doi.org/10.3892/mco.2018.1746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313958/
https://www.ncbi.nlm.nih.gov/pubmed/30655978
http://dx.doi.org/10.3892/mco.2018.1746

Ejemplares similares